Skip to main content
Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder Glioblastoma WHO IV NCH343 cell line

Target:

Sub-type:

Host:

Application:

Cat. #162315

 £575.00
£575.00
× Placeholder Glioblastoma WHO IV NCH270 cell line

Target:

Sub-type:

Host:

Application:

Cat. #162313

 £575.00
£575.00
× Placeholder ENO 1 F423A M2 HAP1 cell line

Target: PCNA interacting domain APIM in the ENO1 gene

Sub-type:

Host:

Application: Cell culture, immunofluorescence, metabolic function assays

Cat. #162181

 £575.00
£575.00
× Placeholder U-2 OS Gal4-p300 Cell Line

Target: Gal4-p300

Sub-type: Continuous

Host:

Application:

Cat. #151579

 £575.00
£575.00
× Placeholder EN2 expressing Flp-In™ T-REx™ 293 cell line

Target:

Sub-type:

Host:

Application:

Cat. #162367

 £575.00
£575.00
× Placeholder EN1 expressing Flp-In™ T-REx™ 293 cell line

Target:

Sub-type:

Host:

Application:

Cat. #162366

 £575.00
£575.00
× A2780ADR Cell Line. 24 hours post plating. Image courtesy of the European Collection of Authenticated Cell Cultures (ECACC) A2780ADR Cell Line

Target: Adriamycin resistance

Sub-type: Continuous

Host:

Application: Study of drug transport, toxicity testing, drug resistance cancer studies

Cat. #152707

 £800.00
£800.00
× Placeholder A375P beta6-puro Cell Line

Target: Integrin beta 6

Sub-type: Continuous

Host:

Application:

Cat. #151626

 £575.00
£575.00
× Placeholder ETV6 expressing Flp-In™ T-REx™ 293 cell line

Target:

Sub-type:

Host:

Application:

Cat. #162364

 £575.00
£575.00

Cart totals

Subtotal £5,400.00
Shipping

Shipping options will be updated during checkout.

Total £5,610.00
Proceed to checkout

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.